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Abstract: BACKGROUND Tenascin C (TN-C) is considered to play a pathophysiological role in mal-
adaptive left ventricular remodeling. Yet, the mechanism underlying TN-C-dependent cardiac dysfunc-
tion remains elusive. METHOD The present study was designed to investigate the effect of hypoxia and
hypertrophic stimuli on TN-C expression in H9c2 cells and its putative regulation by epigenetic mech-
anisms, namely DNA promoter methylation and microRNAs. In addition, rats subjected to myocardial
infarction (MI) were investigated. H9c2 cells were subjected to oxygen and glucose deprivation; incubated
with angiotensin II (Ang II); or human TN-C (hTN-C) purified protein. Hypertrophic and fibrotic mark-
ers, TN-C promoter methylation as well as mir-335 expression were assessed by reverse transcription and
quantitative polymerase chain reaction while TN-C protein levels were assessed by ELISA. RESULTS
Tn-C mRNA expression was markedly increased by both oxygen and glucose deprivation and Ang II
(P < 0.01, respectively). In addition, Ang-II-dependent TN-C upregulation was explained by reduced
promoter methylation (P < 0.05). Cells treated with hTN-C displayed upregulation of Bnp, Mmp2,
฀-Mhc, integrin ฀6 and integrin ฀1. Furthermore, hTN-C treated cells showed a significant reduction in
adenosine monophosphate and adenosine triphosphate levels. In vivo, plasma and myocardial TN-C lev-
els were increased 7 days post MI (P < 0.05, respectively). This increment in TN-C was accompanied
by upregulation of mir-335 (P < 0.01). In conclusion, both hypoxic and hypertrophic stimuli lead to
epigenetically driven TN-C upregulation and subsequent impairment of cellular energy metabolism in
cardiomyoblasts. CONCLUSION These findings might enlighten our understanding on maladaptive left
ventricular remodeling and direct towards a strong involvement of TN-C.
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Epigenetic modulation of tenascin C in the heart:
implications on myocardial ischemia, hypertrophy
andmetabolism
Inês F. Gonçalvesa, Eylem Acara, Sarah Costantinob, Petra L. Szaboa, Ouafa Hamzaa,
Eva V. Tretterc, Klaus U. Kleinc, Sandra Trojanekd, Dietmar Abrahamd, Francesco Panenie,
Seth Hallströmf, Attila Kissa, and Bruno K. Podessera
Background: Tenascin C (TN-C) is considered to play a
pathophysiological role in maladaptive left ventricular
remodeling. Yet, the mechanism underlying TN-C-
dependent cardiac dysfunction remains elusive.
Method: The present study was designed to investigate
the effect of hypoxia and hypertrophic stimuli on TN-C
expression in H9c2 cells and its putative regulation by
epigenetic mechanisms, namely DNA promoter methylation
and microRNAs. In addition, rats subjected to myocardial
infarction (MI) were investigated. H9c2 cells were
subjected to oxygen and glucose deprivation; incubated
with angiotensin II (Ang II); or human TN-C (hTN-C)
purified protein. Hypertrophic and fibrotic markers, TN-C
promoter methylation as well as mir-335 expression were
assessed by reverse transcription and quantitative
polymerase chain reaction while TN-C protein levels were
assessed by ELISA.
Results: Tn-C mRNA expression was markedly increased
by both oxygen and glucose deprivation and Ang II
(P<0.01, respectively). In addition, Ang-II-dependent TN-C
upregulation was explained by reduced promoter
methylation (P<0.05). Cells treated with hTN-C displayed
upregulation of Bnp, Mmp2, b-Mhc, integrin a6 and
integrin b1. Furthermore, hTN-C treated cells showed a
significant reduction in adenosine monophosphate and
adenosine triphosphate levels. In vivo, plasma and
myocardial TN-C levels were increased 7 days post MI
(P<0.05, respectively). This increment in TN-C was
accompanied by upregulation of mir-335 (P<0.01). In
conclusion, both hypoxic and hypertrophic stimuli lead to
epigenetically driven TN-C upregulation and subsequent
impairment of cellular energy metabolism in
cardiomyoblasts.
Conclusion: These findings might enlighten our
understanding on maladaptive left ventricular remodeling
and direct towards a strong involvement of TN-C.
Keywords: epigenetics, hypertrophy, hypoxia, miRNAs,
matrix metalloproteinase, tenascin C
Abbreviations: ADP, adenosine diphosphate; AMP,
adenosine monophosphate; AMPK, AMP-activated protein
kinase; Ang II, angiotensin II; CMC, cardiomyocyte; ECM,
extracellular matrix; hTN-C, human TN-C protein; LCA, left
coronary artery; MI, myocardial infarction; MMP, matrix
metalloproteinase; OGD, oxygen glucose deprivation; PCr,
phosphocreatine; TN-C, tenascin C
INTRODUCTION
L
eft ventricular remodeling describes changes in form,
shape and function following chronic pressure or
volume overload, ultimately ensuing to left ventricu-
lar dilation and heart failure. These changes occur at the
level of the individual cardiomyocyte (CMC) and the extra-
cellular matrix (ECM) components, thereby leading to re-
expression of fetal genes, alterations in expression of
proteins involved in excitation–contraction coupling and
in energy metabolism [1]. b-Receptor blockers and inhib-
itors of the renin–angiotensin system are commonly used to
prevent progression of left ventricular remodeling and
hence development of heart failure due to condition such
as myocardial infarction (MI). Nevertheless, a certain num-
ber of patients is still suffering from heart failure. Therefore,
a better comprehension of the mechanism underlying
pathological left ventricular remodeling is invaluable for
the development of new therapeutic strategies.
In the setting of adverse left ventricular remodeling, the
alteration of ECM components and the degradation by
matrix metalloproteinases (MMPs) lead to progressive
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collagen deposition [2]. Recently, our group for the first time
demonstrated the pathophysiological importance of TN-C,
a large glycoprotein of ECM, in the progression of fibrosis
and left ventricular hypertrophy in mice subjected to
chronic pressure overload [3]. Other investigators have
reported the pivotal role of TN-C in progression of myo-
cardial and vascular remodeling [4,5] In addition, the ele-
vated levels of TN-C in serum and myocardial tissue
samples are accompanied by adverse left ventricular
remodeling following MI [6,7]. Taken together, the
enhanced levels of TN-C in infarcted and hypertrophied
myocardium have been accompanied by left ventricular
dilation and worse clinical outcome. Interstitial fibroblasts
in the vicinity of the injured CMCs are the major source of
TN-C and cumulative data demonstrated that inflammatory
cytokines such as TGF-b, IL-1b, hypoxia and mechanical
stress, exacerbate the synthesis of TN-C [8]. In addition, the
loosening of cell adhesion and upregulation of MMPs
following MI contribute to slippage of myocytes within
the left ventricular wall, resulting in left ventricular wall
thinning and dilatation, a mechanism at least partially
driven by TN-C. Moreover, TN-C is also synthesized by
endothelial and vascular smooth muscle cells as well as
more recently shown by CMC [9]. Accordingly, Ma et al. [10]
demonstrated that low but comparable levels of expression
of long transcripts of TN-C between neonatal CMC and
fibroblast under basal conditions was presented. Consistent
with these findings, CMC and fibroblasts co-cultures treated
with angiotensin II (Ang II) markedly enhanced TN-C
expression, indicating the potential regulatory role of
Ang II on TN-C expression. However, the mechanisms
underlying the interactions between Ang II and TN-C in
CMC remain unclear. More recently, adverse left ventricular
remodeling is associated with epigenetic modifications,
including microRNAs and DNA methylation, which play
a pivotal role in left ventricular hypertrophy and fibrosis
[11,12]. Accordingly, overexpression of mir-335 markedly
reduced the expression of TN-C in hepatic stellate cells [13]
and miR-335 suppressed metastasis through targeting of
TN-C in breast cancer cells [14]. Nevertheless, the expres-
sion profiles of mir-335 in myocardial tissue samples after
MI are unexplored. Therefore, we aimed to investigate
the effects of hypoxic and hypertrophic stimuli on TN-C
expression in H9c2 cells and in rats subjected to MI, and its
putative regulation by epigenetic mechanisms, namely
DNA promoter methylation and microRNAs.
MATERIALS ANDMETHODS
Rat model of myocardial infarction in vivo
Male Sprague–Dawley rats (10–12 weeks old, Department
for Laboratory Animal Science and Genetics, Himberg,
Austria) were anaesthetized by intraperitoneal injection
of a mixture of Xylazin (4mg/kg; Bayer, Leverkusen,
Germany) and Ketamin (100mg/kg; Dr E. Gräub AG, Bern,
Switzerland), intubated and ventilated. Rats were subjected
to permanent ligation of left coronary artery (LCA, MI
group; n¼ 8) or Sham (n¼ 4) as described previously
[15]. The experimental protocol was approved by the Ethics
Committee for Laboratory Animal Experiments at the
Medical University of Vienna and the Austrian Ministry of
Science, Research and Economy (BMWFW-66.009/0023-
WF/V/3b/2016) and in conformation with the Guide for
the Care and Use of Laboratory Animals published by the
US National Institutes of Health (NIH Publication No. 85-23,
revised 1996).
Transthoracic echocardiography
Transthoracic echocardiography was performed on the
anesthetized animal (isoflurane 2–3%) using a Vivid7 sys-
tem GE Healthcare echocardiography machine equipped
with an 11.5MHz 10S sector transducer. Briefly, rats were
placed in a supine position and an echocardiography probe
was placed in gentle contact with the chest. Parasternal
short axis views of the left ventricular cavity were collected
at the level of the papillary muscle. M-mode echocardiog-
raphy was performed. Based on M-mode images, left ven-
tricular ejection fraction (%), as a primary end-point was
assessed in three consecutive beats and averaged. Echocar-
diography was performed prior to and 7 days following MI
in each experimental group.
Histology
Myocardial histology was performed on samples taken 7
days after MI induced in each group. Briefly, hearts were
explanted washed and perfused with saline before being
transferred to a 4% paraformaldehyde solution for 24 h.
After this fixation period, heart sections (5mm)were stained
with hematoxylin and eosin andmounted on glass slides. In
addition, heart sections were stained with Masson–Goldner
to measure collagen contents. Images were acquired by
microscopy (Olympus VS120 Virtual Slide Microscope Sys-
tem; Olympus, Tokyo, Japan) and captured by digital
camera (AVT PIKE F-505C VC 50; Allied Vision Technolo-
gies, Stadtroda, Germany).
In-vitro H9c2 cardiomyoblast culture
H9c2 cardiomyoblasts (ATCC CRL-1446, Manassas, Virginia,
USA) were cultured using M199 complete media [M199
media supplemented with 10% fetal bovine serum, 1%
penicillin and streptomycin, and 1% L-glutamine (Thermo
Fisher Scientific, Waltham, Massachusetts, USA)] as previ-
ously described [3].
Chronic hypoxia as a model of ischemic injury
on H9c2 cells
H9c2 cardiomyoblasts were submitted to periods of oxygen
glucose deprivation (OGD). Hence, 24-well imaging fluo-
rocarbon (FC, MoBiTec GmbH, Goettingen, Germany)
plates were coated with 2% gelatin for 1 h and
1 106 cells/ml were seeded with M199 complete media.
Plates were then cultured under OGD or normoxic con-
ditions at 378C for 6 and 16 h. Afterwards, cardiomyoblasts
were isolated for assessing cell viability or analysis of RNA
as well as protein content.
Cardiomyoblasts in-vitro hypertrophy model
H9c2 cardiomyoblasts were incubated with hypertrophic
inducers as described previously [16]. Briefly, M199 com-
plete media were supplement with 1mmol/l of Ang II
(Sigma Aldrich, St Louis, Missouri, USA) for 48 h. Controls
Gonçalves et al.
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were identically treated with M199 complete media, and
total RNA was isolated.
The effect of exogenous human tenascin C on
cellular hypertrophy
H9c2 cardiomyoblasts were exposed to two different con-
centrations of human TN-C purified protein (hTN-C; Merck
& Co., Burlington, Massachusetts, USA). M199 complete
media supplemented with 1 or 10mg/ml of hTN-C was
added for 24 and 48 h. Controls were also generated using
M199 complete media. Total RNA was isolated and gene
expression analyzed.
Total RNA and miRNA isolation
Total RNA and miRNA were isolated from H9c2 rat cardi-
omyoblasts, as well as from rat myocardium tissue samples
(infarcted area and border zone, depicted in Fig. 1b).
RNeasy Mini kit (Qiagen, Hilden, Germany) and miRNeasy
kit (Qiagen) were used to isolate mRNA and miRNA respec-
tively according to instructions.
Reverse transcription and quantitative
polymerase chain reaction
cDNA was prepared using QuantiTect reverse transcription
kit (Qiagen). Samples were analyzed in duplicate in a
volume of 20ml/well. The initial denaturation step of
15 min at 958C was followed by 45 cycles of 15 s 958C,
30 s 508C and 30 s 728C, using Rotor-Gene Q (Qiagen) and
Rotor-Gene Q series software for Ct value analysis. Relative
gene expression was calculated by 2DDCt method
Analysis of DNA methylation by methylation-
specific polymerase chain reaction
Genomic DNA (gDNA) from H9c2 cells was obtained using
the DNeasy Blood and Tissue Kit according to the manu-
facturer’s instructions (Qiagen). One microgram of gDNA
was denaturated and unmethylated cytosines converted to
uracil in the denatured samples (Cells-to-CpG Bisulfite
Conversion Kit; Thermofisher Scientific). CpG methylation
was quantified by methylation-specific real-time PCR using
100 ng of bisulfite-converted genomic DNA as the template
FIGURE 1 (a) Left ventricular ejection fraction (LVEF) prior to myocardial infarction (MI) and 7 days post MI. (b) Representative Masson-Goldner staining on left ventricular
slices were obtained on day 7 after MI with showing infarcted and border zone. Data are presented as mean SD; n¼4–7. MI. n¼4–7; P<0.001.
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and methylation-specific primers for CpG in the human TN-
C promoter. The methylation level of TN-C promoter was
calculated by using the methylation index, as previously
reported [17].
Reverse transcription and quantitative
polymerase chain reaction for miRNAs
cDNA synthesis was prepared using TaqMan miRNA
reverse Transcription kit according to instructions (cat.
no. 4366596 from Thermo Fisher Scientific). qPCR was
performed using TaqMan universal Master mix UNG (cat.
no. 4324018 from Thermo Fisher Scientific), and mir-335
primer (has-miR-335, assay ID 4427975 from Thermo Fisher
Scientific). Normalization was performed to Ubiquitin 6
(U6 snRNA, assay ID 001973 from Thermo Fisher Scientific).
The thermocycler program was set to 10 min at 958C and 40
cycles of 958C for 10 s and 608C for 55 s using Rotot-Gene Q
(Qiagen). Rotor-Gene Q series software was used for Ct
value analysis and relative gene expression was calculated
by 2DDCt method.
Viability assessment by annexin V/propidium
iodide staining and flow cytometry analysis
The H9c2 cells were stained with fluorescein isothiocya-
nate-annexin V and propidium iodide (Becton, Dickinson
Austria GmbH, Schwechat, Austria) according to manufac-
ture, in order to determine the relative quantity of viable,
early apoptotic, late apoptotic and necrotic cells. Stained
cells were analyzed on a Cytomics FC 500 flow cytometer
(Beckman Coulter, Brea, California, USA).
Tenascin C protein levels assessment by ELISA
Rat Tenascin C ELISA kit from CUSABIO (CSB-E13377r;
Houston, Texas, USA)) was used according to the manu-
facturer instruction. Cellular protein concentration of TN-C
following 6 and 16h of OGD and plasma TN-C levels at 7
days post MI was quantified.
Measurement of high-energy phosphates
The sample preparation and high-performance liquid chro-
matography measurement of adenosine monophosphate
(AMP), adenosine diphosphate (ADP), adenosine triphos-
phate (ATP) and phosphocreatine (PCr) were performed as
previously described [18]. In brief, Untreated (control) or
treated (Ang II; hTN-C) H9c2 cardiomyoblasts were used
for the determination. After trypsinization and mild centri-
fugation (supernatant discarded) cellular proteins were
precipitated with 250ml of perchloric acid (0.4mol/l). After
centrifugation (12 000g), 150ml of the supernatant was
neutralized with 15–20ml of potassium carbonate (2mol/l,
48C). The supernatant (20ml injection volume), obtained
after centrifugation, was used for high-performance liquid
chromatography analysis. Separation was performed on a
Hypersil octadecylsilane column (5mm; 250 4mm I.D.)
using an L-2200 autosampler, two L-2130 HTA pumps and
an L-2450 diode array detector (all: VWR Hitachi, VWR,
Vienna, Austria). Detector signals (absorbance at 214 and
254 nm) were recorded, and the software EZchrom Elite
(VWR) was used for data acquisition and analysis. Energy
charge was calculated according to the following formula:
energy charge¼ (ATPþ 1/2ADP)/(ATPþADPþAMP). The
pellets of the acid extract were dissolved in 1ml of 0.1mol/l
sodium hydroxide and further diluted 1:10 with physiologic
saline for protein determination [BCA (bicinchoninic acid)
Protein Assay, Pierce, Thermo Fischer Scientific, Inc., Rock-
ford, Illinois, USA].
Statistical analysis
Data are presented as mean SD. One-way ANOVA with
Bonferroni post-hoc test was used for multiple comparisons
between the groups and unpaired t test was used for
comparison of two groups. P< 0.05 was considered statisti-
cally significant. Analysis was performed using Prism 6
software (GraphPad Inc., San Diego, California, USA).
RESULTS
Myocardial infarction resulted in upregulation
of tenascin C
There was no difference in baseline left ventricular ejection
fraction between the groups. However, MI (n¼ 7) resulted
in a marked reduction in EF in comparison to baseline
values and Sham-operated group (n¼ 4,P< 0.001) at 7 days
post-infarction (Fig. 1a). In addition, Figure 1b depicted
the extent of MI and shows the infarcted area and border
zone. MI was accompanied by a significant increment of
plasma TN-C concentration (Fig. 2a, P< 0.01). Moreover,
TN-C mRNA expression was increased in the border zone
when compared to the infarcted area (Fig. 2b). In parallel,
there was a significant upregulation of cytokines such
as TGF-b, IL-1b, whereas IL-6 expression remained
unchanged (Fig. 2b). Interestingly, mir-335 expression
was upregulated in the border-zone as compared to non-
infarcted myocardial samples from Sham-operated rats
(Fig. 2c, P< 0.05).
Hypoxia induces tenascin C formation in H9c2
cardiomyoblasts
Figure 3a shows a marked elevation of Tn-c expression
following 6 h of OGD in comparison to the normoxic
condition in H9c2 cells (P< 0.05). In addition, TN-C protein
levels were measured following 6 and 16h of OGD
(Fig. 3b). Protein expression of TN-C was not detectable
under normoxic conditions (data not shown). However,
cells exposed to OGD showed an increase in TN-C protein
concentration at both time points (Fig. 3b). Moreover,
prolonged OGD did not significantly influence mir-335
expression in cells (Fig. 2c, n¼ 4).
Given the key role of DNA methylation in regulating
gene transcription, we investigated TN-C promoter meth-
ylation after exposure to OGD in H9c2 cells. We found
that hypoxia did not affect DNA methylation of the TN-C
promoter as compared to control (Fig. 3d).
Prolonged OGD ultimately triggered cell death (Sup-
plemental Figure 1, http://links.lww.com/HJH/B88, 50%
decrease in viability after 16 h hypoxia). Nevertheless,
H9c2 cells incubated with the hTN-C purified protein for
either 24 or 48 h did not modify cells viability (apoptosis
and necrosis; Supplemental Figure 2, http://links.lww.com/
HJH/B88).
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Epigenetic regulation of tenascin C by
angiotensin II
H9c2 cells incubated with Ang II (1mol/l) showed
an upregulation of Bnp and Tn-C mRNA expression
(Fig. 4a, P< 0.05 and P< 0.01, respectively) as well as a
slightly increase of b-Mhc expression (Fig. 4a). In addition,
H9c2 cells incubated with Ang II also showed an upregu-
lation of mir-355 (Fig. 4b, P< 0.05). It is important to note
that cells exposed to Ang II exhibited a reduced demethyl-
ation of TN-C promoter (Fig. 4c, P< 0.01).
Tenascin C regulates genes involved in left
ventricle remodeling
TN-C is a highly conserved protein, maintaining its homol-
ogy among species. H9c2 cells were incubated with hTN-C
purified protein for either 24 or 48 h. H9c2 cells incubated
with hTN-C markedly increased the expression of Bnp and
b-Mhc after 48 h (Fig. 5a, P< 0.001) as well as time and dose
dependently modified integrin a6 after 48 h incubation
(Fig. 5b, P< 0.01). Integrin b1 expression was slightly
increased after 48 h incubation with hTN-C (Fig. 5b).
Mmp-2 expression was markedly increased in cells after
incubation with hTN-C (Fig. 5a). hTN-C administration also
initiated a temporary upregulation of TgfF-b (Fig. 5c,
P< 0.01). In line with this, dysregulation of Smad 3 and
4 was observed after incubation of the cells with hTN-C
(Fig. 5c, P< 0.05).
Tenascin C impairs cellular energy metabolism
in H9c2 cells
Cells incubated with hTN-C showed a marked reduction in
high-energy phosphate concentration, namely ATP (Fig. 6a,
P< 0.05) and AMP (Fig. 6a, P< 0.05). Moreover, both Ang II
and hTN-C-treated cells showed a tendency towards the
decrease of phosphocreatine (PCr) (Fig. 6a). Energy charge
was similar between all groups (Fig. 6b).
DISCUSSION
We investigated the effect of hypoxia and hypertrophic
stimuli on TN-C expression in H9c2 cells and its putative
regulation by epigenetic mechanisms, namely DNA pro-
moter methylation and microRNAs. Both conditions lead to
an upregulation of TN-C in H9c2 cells. In addition, TN-C
directly regulated genes involved in progression of left
ventricular hypertrophy and heart failure, such as Mmps,
Bnp and integrins. Furthermore, Ang II led to reduced
demethylation of the TN-C promoter, subsequently
FIGURE 2 (a) Plasma tenascin C (TN-C) levels at 7-day post myocardial infarction (MI) measured by ELISA in Sham-operated (Sham) and MI group. (b) Relative mRNA
expression of, Tn-c, Tgf-b, IL1-b and IL-6 and (c) mir-335 expression in left ventricular tissue samples obtained from the border zone (grey bar) and the infarcted area
(green bar). Data are presented as mean SD; n¼4–7. MI. n¼4–7; P<0.05, P<0.01.
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resulting in TN-C upregulation in CMCs. This TN-C upre-
gulation was accompanied by an enhancement in plasma
and tissue of TN-C levels in rats subjected to chronic MI.
Adverse left ventricular remodeling due to MI is accom-
panied by substantial growth on myocyte size, dysregula-
tion of cytoskeleton genes, overactivation of renin
angiotensin aldosterone system, ECM components and
re-expression of fetal genes [19]. Notably, re-expression
and transient upregulation of TN-C in post-MI culminates
in worse clinical outcome [6,7,20], suggesting the patho-
physiological importance of TN-C. Accordingly, recent
studies demonstrated that the peak of TN-C upregulation
in left ventricular tissue samples (border zone and infarcted
area) occurred 5–7 days post-MI [7,21]. In line with these
studies, we found that both circulating and tissue levels of
TN-C was markedly increased at 7 days post-MI. In addi-
tion, H9c2 cells exposed to OGD showed TN-C upregula-
tion. These results are also supported by a recent study [10]
which demonstrated that besides fibroblasts, CMCs are also
capable of producing TN-C under certain conditions.
Therefore, in our study we focused on the impact of TN-
C on CMCs rather than fibroblast. Accordingly, H9c2 cells
exposed to hTN-C showed an upregulation of both hyper-
trophic and fibrotic markers such as Bnp and Smad3.
There is substantial evidence that Tgf-b signaling is an
essential player in inflammatory response and healing after
MI. We found an enhancement of Tgf-b expression in
infarcted myocardium from rats subjected to chronic liga-
tion of LCA. In line with this findings, Tn-C expression was
also upregulated 7 days post-MI, which may indicate a
potential interaction of Tn-C and Tgf-b [22]. Accordingly,
H9c2 cells exposed to hTN-C for 24 h showed a marked
upregulation of Tgf-b. Tgf-b signaling activation by TN-C in
CMC might provide a pro-survival signal and subsequently
lead an improvement of infarct healing [23]. Upregulation of
Tgf-b expression contributes to CMC apoptosis [23] and
promotes fibroblast proliferation as well as ECM degrada-
tion. Therefore, this upregulation of TGF-b plays a central
role in maladaptive post-MI remodeling.
We also investigated the possible epigenetic modifica-
tions – including, non-coding RNAs (mir-335) and DNA
methylation on TN-C expression. Recently, it has been
demonstrated that microRNAs play a significant role in left
ventricular remodeling, in terms of increasing interstitial
fibrosis and activating ECM degradation [24]. However, only
a few studies have investigated the epigenetic control of
TN-C. Chen et al. [25] showed that mir-335 is involved in the
regulation of TN-C expression in hepatic satellite cells. In
addition, mir-335 suppresses the ECM component TN-C
which directly targets the 30 UTR of TN-C [14]. In our OGD
cellular model, the expression level of mir-335 remained
unchanged, whereas Tn-C was upregulated. In contrast,
myocardial tissue samples from either border zone or
infarcted area showed a massive upregulation of mir-335.
FIGURE 3 (a) Tenascin C mRNA and (b) tenascin C (TN-C) protein expression following 6 and 16h of oxygen and glucose deprivation (OGD). (c) mir-335 expression in
H9c2 cells exposed to OGD. (d) TN-C promoter methylation following OGD. n.d., not detected. Data are presented as mean SD; n¼4–6.P<0.05.
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Simultaneously, the mRNA expression of Tn-C within the
same areas was also increased. Based on the inconsistent
data between our results and previous findings, we inter-
pret the discrepancies as follows. We used a different cell
type which implies that there is possible functional differ-
ence in regulation of Tn-c by mir-355 in comparison to
tumor cells and cardiomycyte (H9c2 cells). This is sup-
ported by the findings that we did not observe an up
regulation or downregulation of mir-335 expression in
H9c2 cells after OGD exposure. However, cells exposed
to OGD shown an increase in Tn-C expression. Recently,
Zhu et al. [26] have demonstrated that mir-335 promotes
upregulation of pro-inflammatory cytokines such as TNF-a
and IL-6 in human mature adipocytes. These cytokines also
play a significant role in adverse left ventricular remodeling
post-MI.
In fact, activation of the adrenergic system with associ-
ated upregulation of the renin–angiotensin–aldosterone
system, including Ang II play a major role in progression
of adverse left ventricular remodeling [27,28]. Notably, we
found that H9c2 cells exposed to Ang II resulted in reduced
DNAmethylation of the TN-C promoter, indicating that Ang
II is a potential regulator of TN-C. Moreover, promoter
methylation is an important repressor of gene transcription,
while reduced methylation of CpG sites favors chromatin
accessibility to transcription factors [29]. We observed
changes in TN-C promoter methylation with Ang II but
not with OGD, suggesting that different stimuli (OGD vs.
Ang II) may activate different epigenetic networks. The
growing importance of methylating agents in clinical prac-
tice [30] highlight the possibility to restore TN-C expression
by targeting enzymes involved in DNAmethylation, namely
DNMT3a and 3b.
Adverse left ventricular remodeling is associated with a
marked left ventricular dilatation. In our previous study TN-
C-KO mice showed preserved left ventricular function
which was accompanied by a significantly reduced left
ventricular dilatation [3]. Dysregulation of integrin b1 has
been demonstrated to play a role in CMC apoptosis [31] and
left ventricular dilatation [32]. Furthermore, Hessel et al. [33]
found that pressure overload-induced right ventricular fail-
ure was associated with TN-C upregulation and concomi-
tant reduction of integrin a6. Accordingly, we investigated
the impact of TN-C on integrin b1 expression in H9c2 cells.
Cells exposed to hTN-C for 24 h showed decreased mRNA
expression of integrin b1 when compared to untreated
controls. Interestingly, we found that integrin a6 was
markedly increased after 48 h incubation with hTN-C. This
rise in the integrin a6 levels may also contribute to left
ventricular dysfunction. In addition, TN-C increased the
FIGURE 4 (a) Bnp, tenascin C, and b-Mhc expression in H9c2 cells following 48h incubation with 1mmol/l of angiotensin II (Ang II). (b) Effect of Ang II on mir-335
expression in H9c2 cells. (c) Tenascin C (TN-C) promoter methylation after incubation with Ang II for 48h. Data are presented as mean SD; n¼4–6. P<0.05 and

P<0.01.
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expression of Mmp-2 in H9c2 cells, which further underline
the pathophysiological importance of TN-C in adverse left
ventricular remodeling and left ventricular dilatation.
Besides integrin, Ang II accelerates left ventricular dilation
acting on Ang II receptor [34]. Accordingly, we found an
Ang II-dependent TN-C upregulation on epigenetic levels.
Finally, we investigated the impact of TN-C on cellular
energy metabolism. Of note, dysregulation of myocardial
metabolic processes appears to be a major contributor to
heart failure pathogenesis [35]. By addition of hTN-C to
H9c2 cells, a significant decrease in ATP formation was
observed, revealing an impaired mitochondrial activity as
FIGURE 5 (a) BnpP, b-Mhc and Mmp-2 expression after 24 or 48 h incubation with 1 and 10mg/ml of human tenascin C (TN-C) (hTN-C). (b) mRNA expression of Itg a6
and Itg b1 after 24 and 48h incubation with 1 and 10mg/ml of hTN-C. (c) Effect of hTN-C on Tgf-b and Smad 2, 3 and 4 mRNA expression. Data are presented as
mean SD; n¼4–6. P<0.05, P<0.01 and P<0.001.
FIGURE 6 (a) Effect of human tenascin C (TN-C) (hTN-C) and Ang II treatment on high energy phosphates levels and (b) energy charge after 48 h incubation (hTN-C:
10mg/ml; Ang II: 1mmol/l) in H9c2 cells. Data are presented as mean SD; n¼6. P<0.05.
Gonçalves et al.
1868 www.jhypertension.com Volume 37  Number 9  September 2019
 Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
well as in consequence a reduction of cardiac function.
Similarly, TN-C significantly reduced the levels of AMP as
well as in the total pool of adenine nucleotides. A key player
involved in regulating myocardial metabolism is AMP-acti-
vated protein kinase (AMPK), a regulatory kinase control-
ling numerousmetabolic pathways and deficiency of AMPK
boosts left ventricular dilatation [36]. Nevertheless, further
studies are warranted to explore the interaction of TN-C and
AMPK in dilative cardiomyopathy.
Several limitations of the present study have to be
considered. First, studies of aberrant molecular signaling
process occurring during left ventricular hypertrophy
mostly use CMCs from neonatal rodent hearts. In the
current study, we used the H9c2 cardiomyoblast cell line.
However, previous studies have demonstrated that H9c2
cells and rat neonatal CMCs show almost an identical
hypertrophic response to Ang II [16]. Second, we only
focused on mir-335 and studied the regulatory role of this
miRNA on TN-C regulation. Nevertheless, our study to the
best of our knowledge for the first time showed that mir-335
is upregulated in post MI myocardium. Third, we studied
the regulatory role of Ang II on TN-C promoter in CMCs.
However, major source of TN-C during myocardial remod-
eling are fibroblast. Therefore, further studies are warranted
to clarify the regulatory role of Ang II on promoter activity
in fibroblast or other cells.
In conclusion, our study underlines the potential patho-
physiological importance of TN-C on the CMCs level. Tn-C
was found to be upregulated in H9c2 cells under the
influence of OGD or Ang II. This was accompanied by a
dysregulation in the expression of ECM components such
as Mmp-2 and the cell adhesion receptors integrins. In
addition, Ang II led to a reduced demethylation of TN-C
promoter and H9c2 cells exposed to hTN-C showed an
impairment in energy metabolism. These findings may
contribute to our understanding of TN-C regulation in
the heart, thus encouraging new approaches to prevent
adverse left ventricular remodelling in patients with MI.
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